InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Wednesday, 01/19/2022 1:15:47 PM

Wednesday, January 19, 2022 1:15:47 PM

Post# of 16698
With the support of Hammersmith in theUK and Stroke now strongly related to after effects of COVID this may go pretty fast.

"For Type B and C trials, the notification scheme is not applicable and each application will be fully assessed by the MHRA. They will provide an initial response within 30 days of receipt of a valid application, with an average of 14 days for Phase 1 volunteer studies."